Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin condition -- leading to more accurate, early, and standardised identification ...

The application of AI in diagnosing and identifying AD cases could lead to more standardised identification of the condition.

ATOPIC dermatitis (AD), a chronic inflammatory skin condition, affects millions globally and is linked to systemic immune ...

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

Zoryve is under clinical development by Arcutis Biotherapeutics and currently in Pre-Registration for Psoriasis.

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

Eczema is a common skin condition, but there are many types of eczema out there. Learn how to identify your rash with these ...

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms ...

Opzelura is under clinical development by Incyte and currently in Phase II for Unspecified Dermatological Disorders.

The researchers concluded that tralokinumab is an effective and safe treatment option for moderate-to-severe atopic ...

New data reveals that longer-term lebrikizumab treatment significantly improves outcomes for patients with moderate-to-severe atopic dermatitis who didn’t meet response criteria by week 16.